Edition:
United Kingdom

Champions Oncology Inc (CSBR.OQ)

CSBR.OQ on NASDAQ Stock Exchange Capital Market

7.95USD
17 Aug 2018
Change (% chg)

$0.13 (+1.66%)
Prev Close
$7.82
Open
$7.79
Day's High
$7.96
Day's Low
$7.60
Volume
5,117
Avg. Vol
12,553
52-wk High
$9.34
52-wk Low
$3.00

Chart for

About

Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients... (more)

Overall

Beta: -0.44
Market Cap(Mil.): $38.23
Shares Outstanding(Mil.): 10.99
Dividend: --
Yield (%): --

Financials

  CSBR.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.43 -- --
ROI: -258.97 1.78 14.61
ROE: -289.15 3.28 16.33

BRIEF-Champions Oncology Reports Quarterly Revenue Of $5.1 Million

* CHAMPIONS ONCOLOGY REPORTS QUARTERLY REVENUE OF $5.1 MILLION

15 Mar 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $134.47 +1.99
Abbott Laboratories (ABT.N) $64.72 +0.56
Bayer AG (BAYGn.DE) €78.40 +1.35
Bayer AG (BAYE.F) -- --
GlaxoSmithKline plc (GSK.L) 1,617.00 +7.00
Biocon Ltd (BION.NS) Rs591.30 -6.35

Earnings vs. Estimates